Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


read more


MC Services Sponsors Labiotech Refresh Conference

Labeled „Europe's most refreshing biotech event“ by its organizers, this year’s Labiotech Refresh Conference, and the third edition of Refresh, will take place in Berlin on June 8th! A plattform for meeting Europe's biotech leaders, innovators and enthusiasts in a relaxed and easy-going atmosphere, Refresh features Fireside chats, panel discussions as well as a ‚startup face-off‘, where each of 4 chosen participating start-ups defends and justifies their technology, business plans and delivery facing a panel of judges as well as the questions from the audience. 


Find out more

MC Services sponsors Best Technology Award at the 2017 European Mediscience Awards


MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.


Mediscience Awards 2017 shortlist announced

It is done: after much anticipation, the voting has taken place and the shortlist for the 2017 Mediscience Awards has been announced! A huge congratulation to all the shortlisted companies!

The winners will be crowned on Thursday June 15th at European Mediscience Awards prestigious dinner which is being held at The Brewery, London, EC1. Don’t miss out on Europe’s largest annual awards gathering of private and publicly quoted mediscience companies and their advisors, an absolute must-attend networking event for anybody working in this field.


Click here for the full shortlist.

HPS Home Power Solutions GmbH is Silver Sponsor of ees Forum 2017


Medigene AG: Reports outcome of Annual General Meeting and announces new Supervisory Board Members


SYGNIS AG receives binding commitment for the purchase of shares for up to EUR 3.5 million within the scope of the ongoing capital increases to finance the acquisition of Innova Biosciences Ltd.


MorphoSys Announces That Its Licensee Janssen Reported Updates on the Development of Guselkumab


Ventaleon Appoints Dr. Ulrich Dauer as Chief Executive Officer


MorphoSys to Present at Three Upcoming Conferences


HPS Home Power Solutions GmbH to present XXL storage solution for self-supply at the ees Europe 2017 


ORYX reports positive clinical evidence with oncolytic virus ParvOryx in combination with immuno-oncology drugs


Publication of UK Annual Report and Accounts & Notice of AGM


VAXIMM Announces Data from Phase I Trial in Glioblastoma with Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting